Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Nimesulide/pantoprazole - EMS

Drug Profile

Nimesulide/pantoprazole - EMS

Alternative Names: Pantoprazole/nimesulide - EMS

Latest Information Update: 24 Mar 2021

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator EMS
  • Class 2 pyridinylmethylsulfinylbenzimidazoles; Antipyretics; Antirheumatics; Antiulcers; Benzimidazoles; Gastric antisecretories; Nitrobenzenes; Nonsteroidal anti-inflammatories; Pyridines; Small molecules; Sulfonamides; Sulfoxides
  • Mechanism of Action Calcium channel antagonists; Cyclo-oxygenase 2 inhibitors; Platelet aggregation inhibitors; Proton pump inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • No development reported Dyspepsia; Inflammation

Most Recent Events

  • 24 Mar 2021 No development reported - Phase-III for Dyspepsia in Brazil (PO)
  • 24 Mar 2021 No development reported - Phase-III for Inflammation in Brazil (PO)
  • 28 Nov 2018 Chemical structure info added

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top